Consistent with the idea that elevated mutation load leads to the generation of neoantigens that binds MHC proteins and induces antitumor adaptive immunity, HORMAD1 expression was associated with increased neoantigen counts in these cancers (Fig. 6c). This evidence concerns the gene HLA-C and cancer.